Carboplatin-paclitaxel/nab-paclitaxel with or without pembrolizumab in first-line metastatic squamous NSCLC: Results from the KEYNOTE-407 east Asia subgroup

  • Kato, T.; 
  • Lee, S.; 
  • Cheng, Y.; 
  • Lee, G-W.; 
  • Lee, K.; 
  • 외 12명
Citations

WEB OF SCIENCE

4
제목
Carboplatin-paclitaxel/nab-paclitaxel with or without pembrolizumab in first-line metastatic squamous NSCLC: Results from the KEYNOTE-407 east Asia subgroup
저자
Kato, T.; Lee, S.; Cheng, Y.; Lee, G-W.; Lee, K.; Luft, A.; Trigo, J.; Hui, R.; Balint, B.; Robinson, A.; Okamoto, I.; Gerstner, G. J.; Paz-Ares, L.; Li, X.; Shentu, Y.; Piperdi, B.; Tafreshi, A.
발행일
2018-11
유형
Meeting Abstract
저널명
Annals of Oncology
권
29
페이지
151 ~ 151